Delineating
For any given drug, Certerra's process generates a
map of whole-brain drug-evoked activation (or
inhibition) in the animal model i.e., a whole-brain
map “Pharmacomap™”.
Focusing
Certerra offers pharmacomapping as a CRO to a broad spectrum of pharmaceutical companies developing treatments for neurodevelopmental, psychiatric, and neurodegenerative disorders.